Physician profile
Lauren Deanna Chinnery
NPI 1255863395
$4,334.69
in general payments reported to CMS, 2019-2025
20 companies · $1,773 in 2025
The $1,773 reported for 2025 was more than what 94% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $73.48 · 2021: $162 · 2022: $775 · 2023: $572 · 2024: $733 · 2025: $1,773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,556 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,556.07 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,521.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $1,584.82 | 2023-2025 | Nexplanon |
| Baxter Healthcare | $850.06 | 2023-2025 | Tisseel, Perclot, Seprafilm |
| Pacira Pharmaceuticals Incorporated | $370.08 | 2021-2023 | Exparel |
| Abbvie INC. | $304.40 | 2019-2022 | |
| Intuitive Surgical, INC. | $250.24 | 2022 | |
| Alexion Pharmaceuticals, INC. | $156.41 | 2023-2024 | Ultomiris |
| Avanos Medical | $146.24 | 2022 | |
| Hologic Sales and Service, LLC | $123.88 | 2022-2024 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Amag Pharmaceuticals, INC. | $102.45 | 2019 | |
| Medtronic, INC. | $100.69 | 2022 | |
| Boston Scientific Corporation | $73.48 | 2020 | |
| Radius Health, INC. | $62.54 | 2024 | Tymlos |
| Axonics, INC. | $54.36 | 2022 | |
| Coloplast Corp | $29.56 | 2025 | |
| Conmed Corporation | $28.00 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $23.14 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.00 | 2025 | |
| Minerva Surgical, INC | $19.75 | 2024 | |
| Sage Therapeutics, LLC | $16.89 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $15.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Chinnery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.